Episode 68: The "heart of the matter" for stroke prevention in atrial...
In episode 68, we get to the “heart of the matter” of stroke prevention for atrial fibrillation. We find out from Peter Loewen, that it is all a numbers game, and he gives us the tools to deal with...
View ArticleEpisode 112: Dabigatran versus Warfarin, James versus Mike, Right versus Wrong
In episode 112, Mike and James discuss the who, what, why, where and when of dabigatran in atrial fibrillation. We look at the data, and then discuss what we as individuals would do when making a...
View ArticleEpisode 117: The mind boggles and the heart goes all a flutter
In episode 117, Mike and James delve into the first of a few podcasts on options for atrial fibrillation. In this first podcast they look at ways to assess risks and talk at length about a web-based...
View ArticleEpisode 118: The mind boggles and the heart goes all a flutter - Part 2
In episode 118, James and Mike continue their discussion of atrial fibrillation by going into details about the evidence for treating patients with atrial fibrillation and how to make decisions between...
View ArticleEpisode 126: Questions from near and far and answers from way out - Part II
In episode 126, James and Mike discuss how to do a drugectomy and why one needs to consider evidence, efficacy, side effects, cost, patient preference and that as clinicians we need to do many "n of 1"...
View ArticleEpisode 180: A RELYable ARISTOTELian look at ROCKET science
In episode 180, Mike and James invite Mike Kolber back to go over the three major trials that have compared warfarin to the new oral anticoagulants. We try, with limited success, to put all the science...
View ArticleEpisode 247: How the new anticoagulants compare to warfarin in DVTs and PEs
In episode 247, Mike and James and Mike look at the evidence for the new anticoagulants compared to warfarin in the treatment of DVTs and PEs. At the end we realise the decision between these agents is...
View Article
